Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Dec 30, 2011

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific is reshuffling some of its executives as of the beginning of the New Year.

The company has named Gregory Herrema, currently senior VP and president of Analytical Instruments and an executive officer, to be president of its Biosciences division. Alan Malus, currently senior VP and president of Laboratory Products, will become executive VP and president of Analytical Technologies. Thomas Loewald, who currently is president of Laboratory Equipment, will become senior VP and president of Laboratory Products and an executive officer of the company.


Trevor Heritage will step down from his post as executive VP of corporate development and strategy at Accelrys as of Dec. 31, the company said this week in a filing with the US Securities and Exchange Commission. Under a separation agreement, Heritage will receive a severance of $220,000.


Rosetta Genomics said this week in an SEC filing that Isaac Bentwich has resigned from the firm's board of directors, effective immediately, for personal reasons.


BG Medicine's Pieter van der Meer has resigned from his position as a director and from the board committees on which he serves, the company said in an SEC filing. Van der Meer said his resignation, which will be effective on Dec. 31, was not due to any disagreement with the company related to operations, policies, or practices.


Pacific Biomarkers has named Amar Sethi, as its new chief scientific officer effective Jan. 1. Sethi was a postdoctoral fellow from 2005 to 2008 at the National Heart, Lung, and Blood Institute, , and in 2008 he commenced a clinical chemistry fellowship in the Department of Laboratory Medicine at NIH, overseeing the Immunology Section while continuing his research.


Elisabetta Ullu, a professor of internal medicine and cell biology at the Yale University School of Medicine, has won The American Society for Biochemistry and Molecular Biology's Alice and C.C. Wang award. Ullu won the award, which carries a $35,000 prize, for her lab's studies of the protozoan parasite that causes African sleeping sickness, Trypanosoma brucei, which led to insights about RNA interference.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.